David Martínez-Cuadrón
0000-0001-7540-4091
Hospital Universitari i Politecnic La Fe
7 papers found
Refreshing results…
A scoring system for AML patients aged 70 years or older, eligible for intensive chemotherapy: a study based on a large European data set using the DATAML, SAL, and PETHEMA registries
Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry study
Long-term survival after intensive chemotherapy or hypomethylating agents in AML patients aged 70 years and older: a large patient data set study from European registries
Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial
Evolving treatment patterns and outcomes in older patients (≥60 years) with AML: changing everything to change nothing?
Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study
A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patients
Missing publications? Search for publications with a matching author name.